Overview

Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Oral contraceptives are known to improve menstrual cycles and symptoms in PCOS, however may increase cholesterol. Metformin, a drug to improve insulin resistance, may benefit metabolic state. This study is to determine whether metformin added to oral contraceptive therapy in adolescent women with PCOS improves metabolic state.The study will also test a lifestyle improvement program to reduce weight.
Phase:
Phase 3
Details
Lead Sponsor:
University of Rochester
Treatments:
Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Combined
Metformin